These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28272285)

  • 1. EFFICACY OF INTRAVITREAL INJECTION OF BEVACIZUMAB IN VITRECTOMY FOR PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY RETINAL DETACHMENT: A Meta-analysis of Prospective Studies.
    Zhao XY; Xia S; Wang EQ; Chen YX
    Retina; 2018 Mar; 38(3):462-470. PubMed ID: 28272285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Serial Intrasilicone Oil Bevacizumab Injections in Eyes With Recurrent Proliferative Vitreoretinopathy Retinal Detachment.
    Hsu J; Khan MA; Shieh WS; Chiang A; Maguire JI; Park CH; Garg SJ; Ho AC; Kaiser RS
    Am J Ophthalmol; 2016 Jan; 161():65-70.e1-2. PubMed ID: 26432568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.
    Ghasemi Falavarjani K; Hashemi M; Modarres M; Hadavand Khani A
    Eye (Lond); 2014 May; 28(5):576-80. PubMed ID: 24556886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Injection of Bevacizumab for the Prevention of Postoperative Proliferative Vitreoretinopathy in High-Risk Patients Selected by Laser Flare Photometry.
    Gahon M; Luc A; Zessler A; Pastor G; Angioi-Duprez K; Thilly N; Berrod JP; Conart JB
    Ophthalmologica; 2023; 246(5-6):306-313. PubMed ID: 37769629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-silicone Oil Injection of Methotrexate in Retinal Reattachment Surgery for Proliferative Vitreoretinopathy.
    Falavarjani KG; Hadavandkhani A; Parvaresh MM; Modarres M; Naseripour M; Alemzadeh SA
    Ocul Immunol Inflamm; 2020 Apr; 28(3):513-516. PubMed ID: 31136255
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
    Sundaram V; Barsam A; Virgili G
    Cochrane Database Syst Rev; 2013 Jan; (1):CD006421. PubMed ID: 23440808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomical success rate of pars plana vitrectomy for treatment of complex rhegmatogenous retinal detachment.
    Lumi X; Lužnik Z; Petrovski G; Petrovski BÉ; Hawlina M
    BMC Ophthalmol; 2016 Dec; 16(1):216. PubMed ID: 27938367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
    Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
    Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
    Sundaram V; Barsam A; Virgili G
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006421. PubMed ID: 20614445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.
    Fokkens BT; Mulder DJ; Nugteren MB; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6633-6638. PubMed ID: 27926755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
    Zhao XY; Xia S; Chen YX
    Br J Ophthalmol; 2018 Aug; 102(8):1077-1085. PubMed ID: 29246890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy.
    Roca JA; Yon-Mendoza A; Huamán N; Wu L
    Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):2913-2917. PubMed ID: 33900444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective comparison of 25-gauge vitrectomy for repair of proliferative vitreoretinopathy with or without anterior proliferation.
    Sato T; Emi K; Bando H; Ikeda T
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1895-902. PubMed ID: 25377435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
    Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
    Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.
    Schaub F; Hoerster R; Schiller P; Felsch M; Kraus D; Zarrouk M; Kirchhof B; Fauser S
    Trials; 2018 Jul; 19(1):384. PubMed ID: 30012187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.